Kyron.bio
Latest round
- Seed
Last raised
- May 2025
Total raised
- $6.2M
Investors
- 4
About Kyron.bio
bio is a biotechnology company specializing in advanced protein therapeutics through innovative glycan engineering, enhancing the efficacy and safety of antibody therapeutics for various medical applications.bio, founded in 2022 in Paris, France, focuses on the development of advanced protein therapeutics utilizing glycan engineering. The founder's details are not publicly available.bio specializes in the development of advanced protein therapeutics through innovative glycan engineering. Their core offerings focus on the precise control of glycosylation patterns, enhancing the efficacy and safety of antibody therapeutics. The company serves pharmaceutical firms and research institutions aiming to improve therapeutic drug development, particularly in oncology and immunology, with operations primarily in France and Germany.bio generates revenue through strategic partnerships and collaborations with pharmaceutical companies, emphasizing the commercialization of their glycan engineering technologies. Revenue is typically derived from contractual agreements, including milestone payments and licensing fees.bio's proprietary technologies, thus facilitating a smooth transition from research to market readiness.bio plans to expand into other European Union markets beyond France and Germany, leveraging their innovative capabilities to penetrate new regions by 2026.
Who invested in Kyron.bio
4 investors across 1 round
See all investors in Kyron.bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 12, 2025
Amount
$6.2M
Investors
Questions about Kyron.bio
Who invested in Kyron.bio?
Kyron.bio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kyron.bio raised?
Kyron.bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kyron.bio last raise money?
Kyron.bio's most recent round on record is a Seed, in May 2025.
What does Kyron.bio do?
bio is a biotechnology company specializing in advanced protein therapeutics through innovative glycan engineering, enhancing the efficacy and safety of antibody therapeutics for various medical applications.
Where is Kyron.bio headquartered?
Kyron.bio is headquartered in Paris, France.
Which VCs invest in companies like Kyron.bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Kyron.bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Kyron.bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.